You are here

Abexinostat

Xynomic Starts Ph III Trial of Abexinostat in Renal Cell Carcinoma

CP Wire

Tue, 02/26/19 - 10:04 am

renal cell carcinoma

Xynomic Starts Ph III Trial of Abexinostat in Renal Cell Carcinoma

Tue, 02/26/19 - 10:02 am

renal cell carcinoma

Pharmacyclics, Servier call it quits on a cancer drug

Fierce Biotech

Fri, 09/26/14 - 09:05 am

Is There Pipeline Potential in These 3 Biotech Stocks?

Motley Fool

Thu, 08/8/13 - 09:02 am

Sarepta Therapeutics